MedTrace Logo

Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury Patients

NCT01579500 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-04-25

No results posted yet for this study

Summary

The purpose of this study is to determine whether botulinum toxin A is effective in the treatment of neuropathic pain in spinal cord injury patients.

Conditions

  • Spinal Cord Injury
  • Neuropathic Pain

Interventions

DRUG

Botulinum toxin type A

Subcutaneous injection of botulinum toxin type A

DRUG

normal saline

Subcutaneous injection of normal saline

Sponsors & Collaborators

  • National Health Insurance Service Ilsan Hospital

    collaborator OTHER

  • Medy-Tox

    collaborator INDUSTRY

  • Catholic University of Korea Saint Paul's Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01579500 on ClinicalTrials.gov